176 related articles for article (PubMed ID: 2433872)
1. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study.
Bjerring P; Beck HI; Zachariae H; Søgaard H
Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue.
Staberg B; Roed-Petersen J; Menné T
Acta Derm Venereol; 1989; 69(2):147-50. PubMed ID: 2564233
[TBL] [Abstract][Full Text] [Related]
3. Treatment of psoriasis with 6-aminonicotinamide.
Zackheim HS
Arch Dermatol; 1975 Jul; 111(7):880-2. PubMed ID: 125068
[TBL] [Abstract][Full Text] [Related]
4. Topical methotrexate therapy for psoriasis.
Weinstein GD; McCullough JL; Olsen E
Arch Dermatol; 1989 Feb; 125(2):227-30. PubMed ID: 2913960
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
6. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting.
Ali MF; Salah M; Rafea M; Saleh N
Med Sci Monit; 2008 Dec; 14(12):PI66-74. PubMed ID: 19043379
[TBL] [Abstract][Full Text] [Related]
7. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
Eskicirak B; Zemheri E; Cerkezoglu A
Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
[TBL] [Abstract][Full Text] [Related]
8. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
9. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
Vahlquist A; Törmä H; Carlsson B
Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate in psoriatic arthritis.
Singh YN; Verma KK; Kumar A; Malaviya AN
J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
[TBL] [Abstract][Full Text] [Related]
12. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial.
Morassut P; Goldstein R; Cyr M; Karsh J; McKendry RJ
J Rheumatol; 1989 Mar; 16(3):302-6. PubMed ID: 2498513
[TBL] [Abstract][Full Text] [Related]
13. [Topical administration of cyclosporin in psoriasis vulgaris].
Bunse T; Schulze HJ; Mahrle G
Z Hautkr; 1990 Jun; 65(6):538, 541-2. PubMed ID: 2202163
[TBL] [Abstract][Full Text] [Related]
14. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.
Fraser AD; van Kuijk AW; Westhovens R; Karim Z; Wakefield R; Gerards AH; Landewé R; Steinfeld SD; Emery P; Dijkmans BA; Veale DJ
Ann Rheum Dis; 2005 Jun; 64(6):859-64. PubMed ID: 15528283
[TBL] [Abstract][Full Text] [Related]
15. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study.
Young MM
Pharmatherapeutica; 1982; 3(2):86-92. PubMed ID: 7048339
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil chemotaxis in psoriasis.
Wahba A; Cohen H; Bar-Eli M; Callily R
Acta Derm Venereol; 1979; 59(5):441-5. PubMed ID: 93368
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil and monocyte chemotaxis in methotrexate-treated psoriasis patients.
Ternowitz T; Herlin T
Acta Derm Venereol Suppl (Stockh); 1985; 120():23-6. PubMed ID: 3869414
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
